Purchase Order 15B41226P00000069

Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, was awarded a firm fixed-price purchase order by the Federal Medical Center Rochester on December 30, 2025, for the supply of Tyvaso (treprostinil inhalation solution) in January 2026. The contract carries a ceiling value of $20,713.37 with an ultimate completion date of January 31, 2026, and was not issued under any set-aside designation. The place of performance is Lake Mary, Florida, where the vendor maintains its primary operations as a specialty pharmaceutical distributor serving federal healthcare facilities.

Tyvaso is a critical medication indicated for the treatment of pulmonary arterial hypertension, a rare and serious cardiovascular condition. Priority Healthcare Distribution has established itself as a key supplier of high-cost, complex specialty pharmaceuticals to federal medical centers, correctional facilities, and veterans' healthcare networks across multiple federal agencies, including the Department of Veterans Affairs, Department of Justice Bureau of Prisons, and National Institutes of Health. This purchase order represents a routine pharmaceutical replenishment requirement for the Federal Medical Center Rochester's inpatient medical treatment operations, consistent with the vendor's extensive track record of supplying specialized medications to support federal healthcare delivery.